Latin American Cannabis News
Khiron announces closing of $12.93 million prospectus financing including full exercise of over-allotment option TORONTO, Sept. 12, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV:KHRN,...
Aurora Cannabis to Acquire South American Market Leader ICC Labs Transaction Establishes Strong Foundation for Aurora’s South American Growth Strategy in Medical, Adult Consumer Use and CBD Wellness Markets...
Cronos Group Inc. Unveils Platform in LATAM TORONTO, Aug. 29, 2018 /PRNewswire/ – Cronos Group Inc. (NASDAQ : CRON ) (TSX: CRON) (“Cronos Group” or the “Company”), is pleased to announce that it has entered...
Khiron Announces Pricing of Marketed Short Form Prospectus Offering of Common Shares TORONTO, Aug. 23, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ,...
Khiron Announces Filing of Marketed Short Form Prospectus Offering of Common Shares TORONTO, Aug. 21, 2018 (GLOBE NEWSWIRE) — Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN,...
PharmaCielo Closes Subscription Receipt Financings in Two Tranches for Gross Proceeds of over $39 Million; Provides Corporate Update Harvest of ~200,000 CBD-dominant plants and production of cannabis oil extracts...
Aurora Cannabis International Operational Update: Company Ships Mother Plants to Denmark to Populate Aurora Nordic Phase I MedReleaf Markham Facility now Fully EU GMP Certified EDMONTON, Aug. 13, 2018...
Canopy Growth Announces Further Consolidation of Latin America Assets with Full Acquisition of Spectrum Cannabis Chile SMITHS FALLS, ON and SANTIAGO, Chile, Aug. 9, 2018 /PRNewswire/ – Canopy Growth...
Khiron Signs Letter of Intent to Acquire Colombia’s Leading Health Network Acquisition to deliver network of 100,000 patients that meet Khiron’s indicated targets TORONTO, Aug. 7, 2018 /CNW/ –...
Increased capacity to meet market demand and advance the Company’s objective of addressing the medical needs of 1 million patients in Latin America TORONTO, Aug. 2, 2018 /CNW/ – Khiron Life Sciences Corp....
MedReleaf acquires MED Colombia Cannabis cultivation and extracts production licence in Colombia will service a global supply chain MARKHAM, ON, July 24, 2018 /CNW/ – MedReleaf Corp. (TSX:LEAF) (“MedReleaf”...
Appointment expands business and political network and furthers development of medical cannabis education and research across Latin America TORONTO, July 17, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron”...
Aphria plans for global cannabis leadership with international expansion acquiring leading assets in Latin America and the Caribbean Aphria medical brands to gain exposure to over 300 million people,...
Scythian Biosciences Corp Announces Colcanna SAS as one of the Industry’s First to Receive Key Cannabis Licences for the Cultivation, Extraction, Production and Research of Medical Cannabis for the...
TORONTO, July 5, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), a Canadian integrated medical cannabis company with its core operations in Colombia, announced...
Canopy Growth introduces Latin American subsidiary Canopy LATAM and announces the acquisition of leading Colombian medical cannabis company Announcement pairs Canopy Growth’s industry leading experience with regional expertise and...
TORONTO, June 26, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), a Canadian integrated medical cannabis company with its core operations in Colombia, announced...
Medical Cannabis, Pain and Palliative Care Physician/Researcher will oversee Khiron’s product development and physician’s educational program TORONTO, June 25, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the...
President-Elect’s platform promises significant economic measures to increase foreign investment and international trade TORONTO, June 21, 2018 /CNW/ – Khiron life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN),...
Former DEA Chief of Pharmaceutical Investigations leading Khiron’s best-in-class procedures to self-regulate on diversion control TORONTO, June 19, 2018 /CNW/ – Khiron Life Sciences Corp. (TSXV: KHRN), a Canadian integrated medical...
Khiron Forms Exclusive Strategic Alliance with ILANS, Expanding Distribution Network to Over 500,000 Patients Demonstrates scalability and recurring revenue potential in the Colombian and Latin American markets TORONTO, June...
Khiron Achieves Key Milestone in Mission to Become First Medical Cannabis Company to Bring Products to Market in Colombia Colombian Agricultural Institute (“ICA”) authorization is a significant requirement to...
The Colombian Association of Internal Medicine and the Colombian Association of Neurology agree to support Khiron’s development of medical cannabis education, research and professional programs for nearly 3,000 doctors...
Under Mr. Murphy’s guidance, Khiron becomes only medical cannabis producer in Colombiawith DEA-level security protocols TORONTO, May 31, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV:KHRN), a Canadian...
Khiron Receives INVIMA Approval to Commercialize CBD Products for Colombian Domestic Sale and Export First Fully Licensed Company in Colombia to Receive INVIMA Approval TORONTO, May 30, 2018 /CNW/ – Khiron life Sciences...
